Announcements Trials
Browse Landscape

Phase

Phase 2 41Phase 1 27Phase 3 25Phase 1/2 16Phase NA 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Rhabdoid Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Medulloblastoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Leukemia, Large Granular Lymphocytic 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pinealoma 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Neoplasms 1Neoplasm, Residual 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cytarabine 3Cyclophosphamide 3pembrolizumab 2fludarabine 2Idarubicin 2Etoposide 2venetoclax 1ioversol 1interferon gamma-1b 1fludarabine phosphate 1fluarix 1dubermatinib 1daratumumab 1asparaginase erwinia chrysanthemi recombinant 1alovudine 1Whole-Body Irradiation 1Transplantation 1Sodium Bicarbonate 1Sirolimus 1Photography 1Pemetrexed 1Mycophenolic Acid 1Mesenchymal Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Injections 1Influenza Vaccines 1Immunotherapy, Adoptive 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Gemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia, Myeloid, Acute × Etoposide × Clear all
NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed
26 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07059975 2025-11-04

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Baylor College of Medicine

Phase EARLY_PHASE1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡